APA (7th ed.) Citation

MM, O., A, T., H, K., R, M., BI, A., MB, R., . . . NR, P. (2019). TKI-resistant ALK-rearranged lung adenocarcinoma with secondary CTNNB1 p.S45V and tertiary ALK p.I1171N mutations. Dove Medical Press.

Chicago Style (17th ed.) Citation

MM, Ouseph, Taber A, Khurshid H, Madison R, Aswad BI, Resnick MB, Yakirevich E, Ali SM, and Patel NR. TKI-resistant ALK-rearranged Lung Adenocarcinoma with Secondary CTNNB1 P.S45V and Tertiary ALK P.I1171N Mutations. Dove Medical Press, 2019.

MLA (8th ed.) Citation

MM, Ouseph, et al. TKI-resistant ALK-rearranged Lung Adenocarcinoma with Secondary CTNNB1 P.S45V and Tertiary ALK P.I1171N Mutations. Dove Medical Press, 2019.